EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
166 hedge funds and large institutions have $574M invested in Eagle Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 70 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
-5
Holders Change %
-2.92%
% of All Funds
2.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
50
Reduced
70
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$7.22M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$5.09M |
| 3 |
Two Sigma Advisers
New York
|
+$3.12M |
| 4 |
Two Sigma Investments
New York
|
+$2.49M |
| 5 |
SG Americas Securities
New York
|
+$1.73M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$14.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$5.16M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$4.15M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.14M |
| 5 |
Renaissance Technologies
New York
|
-$2.74M |
